Close

Pfizer Is The First Covid-19 Vaccine to be Approved in Japan

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Eli Lilly’s $3.5 Billion Manufacturing Campus Advances in Upper Macungie, Pennsylvania

A planned $3.5 billion pharmaceutical manufacturing campus in Upper...

Overcoming Resistance-Associated Substitutions (RASs) to Direct-Acting Antivirals

Alt tag: Scientific illustration of Hepatitis C virus interacting...

Genentech Completes Structural Framework at New NC Manufacturing Facility

Genentech raised the final beam of its new Holly...
- Advertisement -

Japan’s Health Ministry has approved Pfizer’s Covid-19 vaccine as the Summer Olympic Games begin in July.

The approval marks the first in the country as it steps up efforts to fight the third wave of infections.

After a government panel recommended approval last week, Japanese Health Minister Norihisa Tamura said the country would approve the vaccine soon, Reuters reported.

The news agency quoted Prime Minister Yoshihide Suga as saying that inoculations will start from the middle of next week, beginning with some 10,000 health workers.

Furthermore, the government plans to obtain enough vaccine doses for its populace of around 126 million by mid-year.

After Japan’s third and most deadly wave of the virus hit late last year, many areas in the country are still under a state of emergency.

Separately, the Drug Regulatory Authority of Pakistan (DRAP) approved the emergency use of Chinese company Cansino Biologics’ Covid-19 vaccine, making it the fourth drug cleared by the regulatory authority to fight against the virus.

This is the second Chinese vaccine approved by the country and the supply of the doses will begin soon.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Latest stories

Related stories

Eli Lilly’s $3.5 Billion Manufacturing Campus Advances in Upper Macungie, Pennsylvania

A planned $3.5 billion pharmaceutical manufacturing campus in Upper...

Overcoming Resistance-Associated Substitutions (RASs) to Direct-Acting Antivirals

Alt tag: Scientific illustration of Hepatitis C virus interacting...

Genentech Completes Structural Framework at New NC Manufacturing Facility

Genentech raised the final beam of its new Holly...

Chugai Pharmaceutical and GSK Sign Exclusive License Agreement for Anti-Dengue Antibody AID351

Japan-based Chugai Pharmaceutical has entered into an exclusive license...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »